Aims/hypothesis The results of studies on the genetics of complex traits need to be replicated and to reach robust statistical significance before they can be considered as established. We here tried to replicate the previously reported association between the TRIB3 Q84R polymorphism (rs2295490) and glucose homeostasis. Methods Three samples of Europeans with fasting glucose <7.0 mmol/l were studied. In sample 1 (n=791), the association between TRIB3 Q84R and impaired glucose regulation (IGR; defined as impaired fasting glucose and/or impaired glucose tolerance and/or type 2 diabetes by OGTT) and insulin sensitivity (ISI), and its interplay with early-phase insulin secretion (i.e. disposition index [DI]) were analysed. Sample 2 (n=374) and sample 3 (n=394) were used to replicate the association with IGR and insulin sensitivity (by glucose clamp), respectively. Genotyping was performed by TaqMan allele discrimination. Results R84 carriers were at higher risk of IGR: OR for the additive model 1.54, p=0.004, and 1.63, p=0.027, in samples 1 and 2, respectively. In sample 1, both ISI (p=0.005) and DI (p=0.043) were progressively lower from QQ to QR and RR individuals. A 'triangulation approach' indicated that the association with IGR was mostly mediated by DI rather than by ISI changes (i.e. being the expected ORs 1.51 and 1.25, respectively). In sample 3, glucose disposal was 38.8±17.7, 33.8±14.4, and 31.6±13.3 μmol min −1 kg −1
effect is due to an alteration of the interplay between insulin sensitivity and secretion. 
Introduction
In insulin-resistant individuals who eventually develop type 2 diabetes, normal or near-normal glycaemia is maintained for many years by compensatory hyperinsulinaemia [1, 2] . Hyperglycaemia eventually ensues when beta cells fail to secrete sufficient insulin to adequately counteract insulin resistance [3, 4] . Thus, an altered interplay between insulin sensitivity and secretion is instrumental for the development of abnormal glucose homeostasis [3, 4] . The mammalian tribbles homologue 3 (TRIB3) is an insulin signalling inhibitor which binds Akt [5] and inhibits [5] [6] [7] insulin-stimulated Akt phosphorylation and subsequent insulin action.
We have recently described a TRIB3 missense single nucleotide polymorphism (SNP) Q84R (i.e. rs2295490, where arginine replaces glutamine at position 84), resulting in a gain-of-function variant [6, 7] . In vitro studies have revealed that the R84 variant is more effective than the Q84 variant in engaging Akt and reducing insulin-mediated Ser473 Akt phosphorylation in human insulin target tissues [6, 7] as well as in insulin-secreting beta cells (C. Wee Liew, J. Bochenski, J. Hu, A.S. Krowleski and R.N. Kulkarni, unpublished data), thus suggesting a deleterious role of this variant on both insulin action and secretion. In vivo, the R84 variant has been associated with insulin resistance [6, 8] and with type 2 diabetes (C. Wee Liew, J. Bochenski, J. Hu, A.S. Krowleski and R.N. Kulkarni, unpublished data); this latter association is likely to be secondary to an altered interplay between insulin secretion and insulin action observed in R84 carriers [9] . As for any genetic study of complex traits, these findings-despite coherence with the biological function of the Q84R polymorphism-need to be replicated as much as possible, with results reaching a high level of statistical significance before they can be considered established. Unfortunately, neither the Q84R polymorphism, nor any other SNP in good linkage disequilibrium with it, is included in the arrays utilised in the publicly available genome-wide association studies for type 2 diabetes and related traits [10, 11] , thus precluding the possibility of performing additional in silico analyses and, conversely, indicating the need for further studies to address this issue.
Thus, in order to accumulate additional data on the association of the TRIB3 R84 variant with abnormal glucose homeostasis we studied several samples of Italians of European ancestry. In addition, we used a 'triangulation approach' [12] to get deeper insights into the mechanisms underlying this association.
Methods

Study participants and design
Three different samples of adult (≥18 years of age) unrelated Italians of European ancestry with fasting plasma glucose <7.0 mmol/l were studied.
Sample 1 comprised 791 unrelated adults (age 18-72 years) from Eastern Sicily, with fasting plasma glucose <7.0 mmol/l, not taking medications known to interfere with glucose and lipid metabolism, who were recruited at the Endocrine Unit of Garibaldi Hospital (Catania, Italy). Of these, 196 were non-obese individuals (BMI <30 kg/m 2 , 80 men and 116 women, age 36.1±12.4 years) recruited among the hospital staff and 595 were obese individuals (BMI≥30 kg/m 2 , 158 men and 437 women, age 35.5± 11.7 years) recruited from the outpatient Obesity Clinic of the same institution. According to the American Diabetes Association 2003 criteria, 465 individuals (58.8%) were normoglycaemic (NG: normal glucose levels both fasting and after OGTT), 326 (41.2%) had impaired glucose regulation (IGR), including impaired fasting glucose (IFG, n=102) and/or impaired glucose tolerance (IGT, n=177) or type 2 diabetes (n=47) as indicated by OGTT. No gene-byobesity status (i.e. non-obese or obese subgroup) interaction was observed in determining indices derived by OGTT data, including the insulin sensitivity index (ISI, see below) (p value for interaction = 0.49) and the disposition index (DI, see below) (adjusted p=0.14); thus, in order to increase the study statistical power, the two subgroups were pooled and analysed together after adjusting for age, sex and BMI. This sample was analysed for the association of the R84 variant with both glucose homeostasis and the interplay between insulin sensitivity and secretion as indicated by the DI obtained from the OGTT-derived data. 2 ) with fasting plasma glucose <7 mmol/l, consecutively recruited at the Department of Experimental and Clinical Medicine of the University 'Magna Graecia' of Catanzaro. Among these, 301 were offspring of patients with type 2 diabetes, with 178 having been previously analysed for the association between insulin sensitivity (as measured by the euglycaemichyperinsulinaemic glucose clamp technique [13] ) and TRIB3 Q84R polymorphism [6] . This sample group was analysed to try to replicate the association observed in sample 1 between the R84 variant and insulin resistance.
All participants underwent physical examination including the measurements of height and weight and were kept on a weight-maintaining diet in the 4 days preceding the study. In sample 1, glucose, insulin, triacylglycerol levels and HDLcholesterol were measured using commercially available kits in blood specimens obtained after an overnight fast and immediately frozen at −20°C. The HOMA of insulin resistance (HOMA-IR) index was calculated as previously described [14] . An OGTT measuring baseline and 120 min glucose values was carried out for sample group 1; glucose and insulin values were also measured before and 30, 60, 90 and 120 min after glucose (75 g) load.
The study protocol was approved by the institutional review boards and performed according to the Helsinki Declaration. Written informed consent was obtained from each participant in the study.
OGTT-derived measurements
The disposition index is the product of the insulinogenic index (IGI) (as calculated according to the formula: [insulin {pmol/l} at 30 min−fasting plasma insulin {pmol/l}]/ [glucose {mmol/l} at 30 min−fasting plasma glucose {mmol/l}]) by the insulin sensitivity index, ISI (as calculated by the following formula: 10,000/√[fasting plasma glucose {mmol/l}×fasting plasma insulin {pmol/l}]×[mean OGTT glucose concentration {mmol/l}×mean OGTT insulin concentration {pmol/l}]). Of note, potential violations of the hyperbolic shape (IGI Â ISI ¼ k, where k is a constant value) were excluded through a goodness-of-fit test for the following non-linear model IGI ¼ k=ISI (R 2 = 0.50, p < 0.0001).
Euglycaemic-hyperinsulinaemic glucose clamp
Euglycaemic-hyperinsulinaemic clamp was performed as previously described [13] . Briefly, after a 12 h overnight fast, a continuous insulin infusion was initiated at the rate of 40 mU/m 2 of body surface area per min, after a priming dose, in order to reach and maintain a steady-state plasma insulin of about 625 pmol/l. Plasma glucose was assessed at 5 min intervals during the 2 h clamp study by a glucose analyser. In the study participants, mean plasma glucose concentration during the last hour of the clamp was 5.16± 0.3 mmol/l. The mean amount of exogenous glucose infused during the last hour of the clamp period was used to calculate the rates of glucose disposal rate, and is expressed as µmol min
Genotyping DNA was extracted from whole blood using a standard method. Genotyping was performed by TaqMan allele discrimination (assay C_16190162_10, Applied Biosystems, Forster City, CA, USA) on the HT7900 platform. The failure rate was <1%. Genotyping quality was checked by directly sequencing 10% of randomly selected samples.
The agreement rate of re-sequenced samples was 100%.
The proportion of the Q84R genotypes obeyed HardyWeinberg equilibrium in all samples studied.
Statistical analysis
The general features of the study participants were expressed as means±SD. The additive genetic model was a priori decided to be tested in all analyses. Because of the skewed distribution, fasting insulin, HOMA-IR and triacylglycerol values as well as ISI, IGI and DI indices, were log transformed before analysis. Continuous variables were compared between groups using one-way or repeated-measurements analysis of covariance (ANCOVA). In particular, for glucose and insulin profiles during OGTT, repeated-measurements ANCOVA models to assess differences over time were carried out via hierarchical linear models; within-patient correlation was accounted for with an unstructured correlation-type matrix [15] . The exact test for Hardy-Weinberg equilibrium was carried out as previously described [16] . Multivariate logistic regression analysis was used to model the effect of the polymorphism on dichotomous outcomes and results were estimated as odd ratios with 95% confidence intervals.
An individual patient's data meta-analysis using a linear mixed model [17] [18] [19] was performed for abnormalities of glucose homeostasis (i.e. either type 2 diabetes or IGR, considered as a categorical trait) and for DI, considered as a continuous trait. Linear mixed models took into account potential between-sample heterogeneity (tested as a genotype-by-sample interaction). An unstructured correlation matrix was assumed. The results of categorical outcomes meta-analyses were reported as odds ratios with 95% confidence intervals, while the results of DI meta-analyses were reported as β and p values.
The possible presence of publication bias was visually assessed by funnel plots and statistically assessed by Begg and Mazumdar rank correlation test [20] and Egger's regression intercept test [21] .
A 'triangulation approach' [12] was followed to determine whether association between polymorphisms of TRIB3 and IGR might be mediated by DI and ISI. The effect size per minor allele of TRIB3 polymorphism for DI and ISI level was estimated by a linear regression analysis. The OR per minor allele of TRIB3 polymorphism for IGR and the OR of DI and ISI for IGR was estimated by logistic regression analysis including age and sex as confounders.
A p value <0.05 was considered significant. All analyses were performed using SPSS Version 15.0 (Chicago, IL, USA) and SAS Release 9.1 (SAS Institute, Cary, NC, USA).
Results
TRIB3 Q84R polymorphism and abnormal glucose homeostasis in samples 1 and 2
For sample 1, the proportion of the TRIB3 genotypes was significantly different in NG participants as compared with individuals with IGR, with the risk of IGR being increased in individuals carrying the R84 variant (Table 1) . Similar data were obtained for sample 2 ( . Although this trend is intriguing and might deserve further attention, the number of individuals in each subgroup is too small to allow any conclusion to be drawn. The results of meta-analysis of these and recently published data, indicating a significant association with abnormalities of glucose homeostasis (either type 2 diabetes or IGR), are shown in Fig. 1a . Given the stronger association with earlyonset type 2 diabetes (i.e. before age 45 years) observed in our previous study [9] , meta-analysis was also performed for early-onset forms of abnormal glucose homeostasis (Fig. 1b) .
TRIB3 Q84R polymorphism and intermediate metabolic traits in sample 1
Baseline characteristics The baseline features of individuals in sample 1, stratified according to the TRIB3 Q84R genotype, are shown in Table 2 and indicate that the R84 variant, especially in the homozygous state, was associated with higher fasting insulin and HOMA-IR index (Table 2) . Also, fasting glucose and triacylglycerol levels tended to be different across genotype groups, though the differences did not reach statistical significance (Table 2 ).
Glucose and insulin profiles during OGTT Repeatedmeasurements ANCOVA models to assess differences across genotypes over time showed that plasma glucose and insulin levels during OGTT were progressively higher from this study and recently published data reporting a similar association [9] ; the results obtained in a total number of 1,436 individuals, confirmed the association (adjusted β (SE) of log DI for each R84 allele=−0.15 (0.04), adjusted p=0.0007). We then asked whether the R84 effect on the risk of IGR was mediated either by DI or by ISI changes and tested it by a 'triangulation approach' in sample 1, for whom all the data needed to test these hypotheses were available. The observed OR for IGR (1.54) was virtually identical to the expected one when DI (i.e. 1.51; Fig. 3 ) was taken into account, but not when ISI (i.e. 1.25) was taken into account, thus supporting the idea that changes in DI, more than in ISI, are likely to mediate the effect of R84 on the risk of IGR.
TRIB3 Q84R polymorphism and insulin sensitivity in sample 3 In order to get further insights about the role of the R84 variant on insulin sensitivity, an additional sample of 394 individuals who underwent the euglycaemichyperinsulinaemic glucose clamp was analysed. Preliminary data on 178 of these individuals have been already reported [6] . Insulin sensitivity as indicated by insulin-stimulated glucose disposal was progressively lower in QQ, QR and RR individuals (38.8±17.7, 33.8±14.4 and 31.6±13.3 μmol
, respectively, p=0.022). This association did not change much after adjusting for age, sex and BMI (p=0.05).
Discussion
We here report that the TRIB3 R84 variant is associated with altered glucose homeostasis in Europeans from Italy, recruited on the basis of having a fasting glucose level in the non-diabetic range (i.e. below 7.0 mmol/l). Virtually identical results were obtained in two different heterogeneous samples, thus providing evidence of formal replication. Of note, obtaining similar results in samples which are clinically heterogeneous increases the chance that our finding is a generalisable one.
When the current data are meta-analysed with those previously published for the association with type 2 diabetes [9] , the statistical association becomes quite robust, especially for abnormal glucose homeostasis before age 45 years. In addition, we also report that individuals carrying the R84 variant are characterised by altered interplay between insulin sensitivity and secretion as indicated by reduced DI values for OGTT. These data too represent a formal replication of a previous finding [9] ; also in this case, when present and previous [9] data are metaanalysed a quite robustly significant association is reached. Taken together, these and previous [9] data suggest that the TRIB3 R84 variant exerts a deleterious role on glucose homeostasis by affecting the interplay between insulin sensitivity and insulin secretion; the subtle equilibrium is instrumental for the maintenance of glucose homeostasis TRIB3 R84 DI p=0.009. Repeated-measurements ANCOVA models were used to assess differences across genotypes over time according to an additive genetic model. All data were adjusted for sex, age and BMI [22, 23] . To test this possibility a 'triangulation approach' was used [12] ; as a matter of fact, the observed and expected ORs for IGR were virtually identical, strongly supporting our hypothesis.
A few differences between present and previous [9] findings on insulin sensitivity and the risk of IGR as well as the absolute amount of early phase insulin secretion deserve some comment. In contrast to the present study, no association between the R84 variant and insulin resistance and IGR was previously observed [9] . It is of note that, as per different selection criteria, individuals with type 2 diabetes at OGTT were included in the present but not in the previous [9] study, thus limiting in the latter one the distribution toward the high end of the spectrum of insulin sensitivity. This might have reduced the power to detect a significant association between the R84 variant and both insulin resistance and abnormalities of glucose homeostasis. Overall, given these conflicting results we tested in an additional sample the association of the R84 variant with insulin resistance as measured by the gold-standard technique, the euglycaemic-hyperinsulinaemic glucose clamp [13] . The data obtained further support the role of R84 in affecting insulin sensitivity.
A second difference refers to absolute values of earlyphase insulin secretion, as indicated by the IGI, which was reduced in R84 carriers in a previous [9] , but not in the present, study. Absolute insulin secretion is partly determined by insulin sensitivity in the sense that it depends on the amount of insulin needed to maintain normoglycaemia. It is therefore expected that a condition of insulin resistance, as in R84 carriers in the present study, exerts an increased stimulus for insulin secretion; thus, even in the presence of beta cell dysfunction, insulin resistance may well explain similar IGI values observed across genotype groups as was found in the present study. What is really of note from a pathophysiological perspective is that, regardless of the observed differences in absolute values of insulin secretion and/or sensitivity, the interplay between these two variables, as indicated by DI-the best predictor of future type 2 diabetes [22, 23] -is similarly reduced in R84 carriers both in the previous [9] and the present study. As for any genetic study of complex traits, data replication is of particular importance in order to reduce the risk of falsepositive results and to accumulate data aimed at establishing a new finding by reaching a high level of statistical significance.
In functional studies on transfected cells, an inhibitory role of R84 variant on insulin-stimulated Akt phosphorylation has been observed in vitro in both cells from peripheral insulin target tissues [6, 7] and insulin-secreting beta cells (C. Wee Liew, J. Bochenski, J. Hu, A.S. Krowleski and R.N. Kulkarni, unpublished data), making plausible a direct role of this variant on both in vivo insulin sensitivity and insulin secretion. A similar deleterious role on both insulin sensitivity and secretion has been reported for other nonsynonymous genetic variations of insulin signalling genes, including IRS-1 (also known as IRS1) G972R [24] [25] [26] and ENPP1 K121Q [27] [28] [29] polymorphisms. Taken together, present and previous genetic data are consistent with a pathogenic role of altered insulin signalling in inducing both peripheral insulin resistance and impaired insulin secretion [30] .
In conclusion, the present study serves the important function of confirming that, among individuals of Southern European ancestry, the TRIB3 R84 variant is associated with an increased risk of abnormal glucose homeostasis. The present data also strengthen the previous hypothesis [9] that this association is mediated by an abnormal interplay between insulin sensitivity and insulin secretion; despite this replication we acknowledge that, as in any crosssectional study, association cannot guarantee a cause-andeffect relationship and that only prospective data can establish such a relationship. We also acknowledge that further replication attempts-either by studying new samples (possibly comprising individuals other than Southern Europeans) or by in silico analysis of databases that are presently not publicly available-are needed before TRIB3 can be conclusively listed among genes able to modulate the susceptibility to abnormal glucose homeostasis.
